Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF).
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Multicenter, prospective, randomized, investigator blind, controlled clinical trial. Two
parallel groups, one receiving the test drug hMG (hMG-IBSA, IBSA Institut Biochimique sa) and
the other the reference drug hMG (Menopur, Ferring Pharmaceuticals, Inc.).